Autoimmune (idiopathic) thrombocytopenic purpura

Lancet

Volumn 349, Issue 9064, 1997, Pages 1531-1536

  Karpatkin, Simon ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; IMMUNOGLOBULIN G ANTIBODY; RHESUS D ANTIBODY; VINCRISTINE;

ALOPECIA; AMENORRHEA; ANTIBODY PRODUCTION; AUTOIMMUNITY; BONE MARROW SUPPRESSION; CLINICAL FEATURE; DIAGNOSIS; DRUG MEGADOSE; DRUG RESISTANCE; DRUG THERAPY; EPIDEMIOLOGY; ETIOLOGY; HEADACHE; HEMORRHAGIC CYSTITIS; HUMAN; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LONG TERM CARE; MUSCLE CRAMP; MYALGIA; NAUSEA; NEUTROPENIA; NEWBORN DISEASE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX RATIO; SIDE EFFECT; SPLENECTOMY; STROKE; SURGERY; THROMBOCYTE COUNT; VIRUS INFECTION; VOMITING; WEIGHT GAIN;

EID: 0031011452     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)12118-8     Document Type: Review

References (48)

1. Karpatkin S. Autoimmune thrombocytopenic purpura. Semin Hematol 1985; 22: 260-88.
2. Hirsch E, Dameshek W. Idiopathic thrombocytopenia: review of 89 cases with particular reference to the differentiation and treatment of acute (self limited) and chronic types. Arch Intern Med 1951; 88: 701-28.
3. Karpatkin S. Heterogeneity of human platelets. IV. Correlation of platelet function with platelet volume. Blood 1978; 51: 307-16.
4. Garg SK, Amorosi EL, Karpatkin S. Use of the megathrombocyte as an index of megakaryocyte number. N Engl J Med 1971; 283: 11-17.
5. Chang M, Suen Y, Meng G, et al. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and IL-11 during thrombocytopenia: insight into regulation of platelet production. Blood. 1996; 88: 3354-62.
6. Kurata Y, Miyagawa S, Kosugi S, et al. High titer anti-nuclear antibodies, anti-SSA/RO antibodies with idiopathic thrombocytopenic purpura. Thromb Hemostas 1994; 71: 184-87.
7. Stasi R, Stipa E, Masi M, et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84: 4203-08.
8. Rabinowitz Y, Dameshek W. Systemic lupus erythematosus after "idiopathic" thrombocytopenic purpura: a review: a study of systemic lupus erythematosus occurring after 78 splenectomies for "idiopathic" thrombocytopenic purpura with a review of the pertinent literature. Ann Intern Med 1960; 52: 1-28.
9. Best WR, Darling DR. A critical look at the splenectomy -SLE controversy. Med Clin N Am 1962; 46: 19.
10. Hymes K, Blum M, Lackner H, et al. Easy bruising, thrombocytopenia and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med. 1981; 94: 27-30.
11. Epstein R, Lozner E, Coffey T, et al. Congenital thrombocytopenic purpura: purpura hemorrhagica in pregnancy and in the newborn. Am J Med 1950; 9: 44-56.
12. Karpatkin S, Strick N, Karpatkin M, Siskind G. Cumulative experience on the detection of anti-platelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosis and other clinical disorders. Am J Med 1972; 52: 776-85.
13. Burrows R, Kelton J. Fetal thrombocytpenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463-66.
14. Burrows R, Kelton J. Pregnancy in patients with idiopathic thrombocytopenic purpura: Assessing the risks for the infant at delivery. Obstet Gynecol Survey 1993; 48: 781-88.
15. Flug F, Karpatkin M, Karpatkin S. Should all pregnant women be tested for their platelet PLA(Zw, HPA-1) phenotype? Br J Haematol 1994; 86: 1-5.
16. Harrington W, Minnich V, Hollingsworth J, et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951; 38: 1-10.
17. Karpatkin S, Siskind G. In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood 1969 ; 33: 795-812.
18. Dixon R, Rosse W, Ebbert L. Quantitative determination of antibody in idiopathic thrombocytopenia purpura. N Engl J Med 1975; 292: 230-35.
19. Kernoff L, Blake K, Shackleton D. Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia. Blood 1980; 55: 730-33.
20. Hymes K, Shulman S, Karpatkin S. A solid-phase radioimmunoassay for bound anti-platelet antibody: studies on 45 patients with autoimmune platelet disdorders. J Lab Clin Med. 1979; 94: 639-48.
21. Cines D, Schreiber A. Immune thrombocytopenia: use of a Coombs antiglobulin test to detect IgG and C3 on platelets. N Engl J Med. 1979; 300: 106-11.
22. Fujisawa K, Tani P, Piro L, McMillan R. The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 1993; 81: 2872-77.
23. George J, Saucerman S. Platelet IgG, IgA, IgM and albumin: Correlation of platelet and plasma concentrations in normal subjects and in patients with ITP or dysproteinemia. Blood. 1988; 72: 362-65.
24. Lurhuma A, Riccomi H, Masson P. The occurrence of circulating immune complexes and viral antigens in idiopathic thrombocytopenic purpura. Clin Exp Immunol 1977; 28: 49-55.
25. 2 mediated and a function of storage. Blood 1992; 80: 3164-72.
26. Karpatkin S, Strick N, Siskind G. Detection of splenic antiplatelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol 1972; 23: 167-76.
27. McMillan R, Longmire R, Yelenosky R, et al. Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombocytopenic purpura. N Engl J Med. 1972; 286: 681-84.
28. VanLeeuwen EF, VanderVen JTHM, Egelfriet CP, et al. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 1982; 59: 23-26.
29. Fujisawa K, O'Toole TE, Tani P, et al. Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein Ilia in patients with chronic immune thrombocytopenic purpura. Blood 1991; 77: 2207-213.
30. Fujisawa K, Tani P, McMillan R. P late let-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombopcytopenic purpura patients often binds to divalent cation-dependent antigens. Blood 1993; 81: 1284-89.
31. Beardsley DJS, Spiegel JE, Jacobs MM, Handin RI, Lux SEI. Platelet membrane glycoprotein Ilia contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest 1984; 74: 1701-07.
32. Woods VLJ, Kurata Y, Montgomery RR, et al. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984; 64: 156-60.
33. Kekomaki R, Dawson B, McFarland J, Kunicki TJ. Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. J Clin Invest 1991; 88: 847-54.
34. Branehog I, Kutti J, Ridell B, et al. The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura. Blood 1975; 45: 551.
35. Harker L. Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol 1970; 19: 95-104.
36. Najean Y, Ardaillou N, Dresch C, et al. The platelet destruction site in thrombocytopenic purpura. Br J Haematol 1967; 13: 409-26.
37. Ballem PJ, Segal GM, Stratton JR, et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 80: 33-40.
38. Karpatkin S, Garg S, Siskind G. Autoimmune thrombocytopenic purpura and the compensated thrombocytolytic state. Am J Med 1971: 51: 1-4.
39. Greendyke R, Bradley E, Swisher S. Studies of the effects of administration of ACTH and adrenal corticosteroids on erythrophagocytosis. J Clin Invest 1965; 44: 746-53.
40. Shulman NR, Weinrach RS, Libre EP, et al. The role of the reticuloendothelial system in the pathogensis of idiopathic thrombocytopenic purpura. Trans Assoc Am Physns 1965; 78: 374-90.
41. Ruiz P, Gomez F, King M, Lopez R, Darby C, Schreiber A. In vivo glucocorticoid modulation of guinea pig splenic macrophage Fc gamma receptors. J Clin Invest 1991; 88 : 149-57.
42. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981; 304: 1135-47.
43. Jacob H, MacDonald R, Jandl J. Regulation of spleen growth and sequestering function. J Clin Invest 1963; 42: 1476.
44. Whitaker A. Infection and the spleen: Association between hyposplenism, pneumococcal sepsis and disseminated intravascular coagulation. M JA 1969; i: 1213-??.
45. Imbach P, Barandun S, d'Appuzo V, et al. High-dose intravenous gamma globulin for idiopathic thrombocytopenia purpura in childhood. Lancet 1981; i: 1228-31.
46. Bussel JB, Kimberly RP, Inman RD, et al. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983; 62: 480-86.
47. Salama A, Kiefel V, Amberg R, Mueller-Eckhardt C. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rho[D]). Blut 1984; 49: 29-35.
48. Blanchette V, Imbach P, Andrew M, et al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703-07.